Current portrait of LC-fILD: from epidemiology to clinico-patholo-radiological presentation and prognosis

M. Funke-Chambour (Bern, Switzerland)

Source: Virtual Congress 2021 – Lung cancer and fibrotic interstitial lung diseases: a challenging association for pulmonologists

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Funke-Chambour (Bern, Switzerland). Current portrait of LC-fILD: from epidemiology to clinico-patholo-radiological presentation and prognosis. Virtual Congress 2021 – Lung cancer and fibrotic interstitial lung diseases: a challenging association for pulmonologists

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Tuberculosis in the elderly: clinical presentation and outcome
Source: Annual Congress 2007 - Medical and surgical treatment of susceptible and resistant tuberculosis
Year: 2007


Microbiological diagnosis and clinical outcome: where are we?
Source: Annual Congress 2008 - Is microbiological diagnosis of community-acquired pneumonia possible and useful?
Year: 2008

Tracheobronchomalacia in children: pathophysiology and clinical presentation
Source: International Congress 2019 – Tracheobronchomalacia in children
Year: 2019


Late Breaking Abstract - Atypical clinical and radiological presentation of SARS-CoV-2 infection in the elderly.
Source: Virtual Congress 2020 – COVID-19 clinical studies
Year: 2020


The changing epidemiology of pulmonary hypertension: disease characteristics and clinical outcome over two decades of the swiss registry
Source: Virtual Congress 2021 – Pulmonary hypertension in the COVID-19 pandemic and beyond
Year: 2021


COVID-19 epidemiology and prevention: Global update
Source: ERS Course 2021 - COVID-19: State of the art
Year: 2021

Current and emerging approaches to the genetic diagnosis of chILDs
Source: International Congress 2014 – Interstitial lung disease (ILD) in children
Year: 2014



NTM: an overview of changing epidemiology
Source: Virtual Congress 2021 – New insights into nontuberculous mycobacteria disease: from diagnosis to treatment
Year: 2021


Advances in knowledge of global epidemiology, pathogenesis and risk factors
Source: Annual Congress 2008 - PG12 - Challenges in pulmonary embolism: hot issues and interactive cases (jointly organised with ACCP)
Year: 2008


Slow-growing lung cancer as an emerging entity: from screening to clinical management
Source: Eur Respir J 2013; 42: 1706-1722
Year: 2013



What’s new in the epidemiology of asthma?
Source: Virtual Congress 2021 – Paediatric year in review
Year: 2021


Update on biology and management of mesothelioma
Source: Eur Respir Rev, 30 (159) 200226; 10.1183/16000617.0226-2020
Year: 2021



Sarcoidosis: imagiological findings and their impact on the disease outcome
Source: International Congress 2018 – Granulomatous disorders: heterogeneous diseases with variable management
Year: 2018


Sarcoidosis in Iceland: a nationwide study of epidemiology, clinical picture and environmental exposure
Source: ERJ Open Res, 7 (4) 00550-2021; 10.1183/23120541.00550-2021
Year: 2021



The disease model: implications for clinical practice
Source: Eur Respir J, 51 (4) 1800188; 10.1183/13993003.00188-2018
Year: 2018



From patients to research laboratories and back: overview of the major scientific achievements and their impact in TB diagnosis, clinical management and control
Source: Annual Congress 2013 –The best of TB PANNET
Year: 2013


Clinical trial landscape for M/XDR-TB: current evidence and future perspectives
Source: International Congress 2019 – Recent developments and future perspectives in the diagnosis and treatment of tuberculosis
Year: 2019